Transactiva was founded in 2001 by three researchers with proven experience in molecular biology, genetic engineering and rare disease
The staff is dedicated to industrial research and experimental development and all employees have strong, specific and complementary skills in pharmaceutical, medical and plant biotechnology. Transactiva’s president and scientific director, Dr. Bruno Bembi, has a key role in guiding the company’s research trajectory, thanks to his lifelong experience as pediatric geneticist and his specific expertise in rare diseases.

 

Board of Directors:

Bruno Bembi, MD, company founder, pediatrician and geneticist (President)

Anna Rossi, entrepreneur

Paolo Cristin, chartered accountant